Literature DB >> 19553551

Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.

Martha Brown1, Rose Kowalski, Julie Zorman, Xin-Min Wang, Victoria Towne, Qinjian Zhao, Susan Secore, Adam C Finnefrock, Tim Ebert, Greg Pancari, Kevin Isett, Yuhua Zhang, Annaliesa S Anderson, Donna Montgomery, Leslie Cope, Tessie McNeely.   

Abstract

In an effort to characterize important epitopes of Staphylococcus aureus iron-regulated surface determinant B (IsdB), murine IsdB-specific monoclonal antibodies (MAbs) were isolated and characterized. A panel of 12 MAbs was isolated. All 12 MAbs recognized IsdB in enzyme-linked immunosorbent assays and Western blots; 10 recognized native IsdB expressed by S. aureus. The antigen epitope binding of eight of the MAbs was examined further. Three methods were used to assess binding diversity: MAb binding to IsdB muteins, pairwise binding to recombinant IsdB, and pairwise binding to IsdB-expressing bacteria. Data from these analyses indicated that MAbs could be grouped based on distinct or nonoverlapping epitope recognition. Also, MAb binding to recombinant IsdB required a significant portion of intact antigen, implying conformational epitope recognition. Four MAbs with nonoverlapping epitopes were evaluated for in vitro opsonophagocytic killing (OPK) activity and efficacy in murine challenge models. These were isotype switched from immunoglobulin G1 (IgG1) to IgG2b to potentially enhance activity; however, this isotype switch did not appear to enhance functional activity. MAb 2H2 exhibited OPK activity (> or =50% killing in the in vitro OPK assay) and was protective in two lethal challenge models and a sublethal indwelling catheter model. MAb 13C7 did not exhibit OPK (<50% killing in the in vitro assay) and was protective in one lethal challenge model. Neither MAb 13G11 nor MAb 1G3 exhibited OPK activity in vitro or was active in a lethal challenge model. The data suggest that several nonoverlapping epitopes are recognized by the IsdB-specific MAbs, but not all of these epitopes induce protective antibodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553551      PMCID: PMC2725548          DOI: 10.1128/CVI.00085-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  31 in total

Review 1.  Guidelines for the management of intravascular catheter-related infections.

Authors:  L A Mermel; B M Farr; R J Sherertz; I I Raad; N O'Grady; J S Harris; D E Craven
Journal:  Infect Control Hosp Epidemiol       Date:  2001-04       Impact factor: 3.254

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections.

Authors:  J P Burnie; R C Matthews; T Carter; E Beaulieu; M Donohoe; C Chapman; P Williamson; S J Hodgetts
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections.

Authors:  Kevin B Laupland; Deirdre L Church; Melissa Mucenski; Lloyd R Sutherland; H Dele Davies
Journal:  J Infect Dis       Date:  2003-04-15       Impact factor: 5.226

5.  Passage of heme-iron across the envelope of Staphylococcus aureus.

Authors:  Sarkis K Mazmanian; Eric P Skaar; Andrew H Gaspar; Munir Humayun; Piotr Gornicki; Joanna Jelenska; Andrzej Joachmiak; Dominique M Missiakas; Olaf Schneewind
Journal:  Science       Date:  2003-02-07       Impact factor: 47.728

Review 6.  Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme.

Authors:  Eric P Skaar; Olaf Schneewind
Journal:  Microbes Infect       Date:  2004-04       Impact factor: 2.700

7.  Staphylococcus aureus capsule type 8 antibodies provide inconsistent efficacy in murine models of staphylococcal infection.

Authors:  James Cook; Robert Hepler; Greg Pancari; Nelly Kuklin; Hongxia Fan; Xin-Min Wang; Leslie Cope; Charles Tan; Joseph Joyce; Jan Onishi; Donna Montgomery; Annaliesa Anderson; Tessie McNeely
Journal:  Hum Vaccin       Date:  2009-04-10

8.  Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.

Authors:  Kenji M Cunnion; Daniel K Benjamin; C Garren Hester; Michael M Frank
Journal:  J Lab Clin Med       Date:  2004-06

9.  The key role of peptidoglycan in the opsonization of Staphylococcus aureus.

Authors:  P K Peterson; B J Wilkinson; Y Kim; D Schmeling; S D Douglas; P G Quie; J Verhoef
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

10.  Identification of a novel iron regulated staphylococcal surface protein with haptoglobin-haemoglobin binding activity.

Authors:  Agnieszka Dryla; Dieter Gelbmann; Alexander von Gabain; Eszter Nagy
Journal:  Mol Microbiol       Date:  2003-07       Impact factor: 3.501

View more
  23 in total

Review 1.  Exploring Staphylococcus aureus pathways to disease for vaccine development.

Authors:  Andrea DeDent; Hwan Keun Kim; Dominique Missiakas; Olaf Schneewind
Journal:  Semin Immunopathol       Date:  2011-12-01       Impact factor: 9.623

2.  The iron-regulated surface determinant B (IsdB) protein from Staphylococcus aureus acts as a receptor for the host protein vitronectin.

Authors:  Giampiero Pietrocola; Angelica Pellegrini; Mariangela J Alfeo; Loredana Marchese; Timothy J Foster; Pietro Speziale
Journal:  J Biol Chem       Date:  2020-06-04       Impact factor: 5.157

3.  Sortases, Surface Proteins, and Their Roles in Staphylococcus aureus Disease and Vaccine Development.

Authors:  Olaf Schneewind; Dominique Missiakas
Journal:  Microbiol Spectr       Date:  2019-01

4.  Human mAbs to Staphylococcus aureus IsdA Provide Protection Through Both Heme-Blocking and Fc-Mediated Mechanisms.

Authors:  Monique R Bennett; Robin G Bombardi; Nurgun Kose; Erica H Parrish; Marcus B Nagel; Robert A Petit; Timothy D Read; Kevin L Schey; Isaac P Thomsen; Eric P Skaar; James E Crowe
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

5.  Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice.

Authors:  Antonina Torre; Marta Bacconi; Chiara Sammicheli; Bruno Galletti; Donatello Laera; Maria Rita Fontana; Guido Grandi; Ennio De Gregorio; Fabio Bagnoli; Sandra Nuti; Sylvie Bertholet; Giuliano Bensi
Journal:  Infect Immun       Date:  2015-05-26       Impact factor: 3.441

6.  Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.

Authors:  Somayeh Delfani; Ashraf Mohabati Mobarez; Abbas Ali Imani Fooladi; Jafar Amani; Mohammad Emaneini
Journal:  Med Microbiol Immunol       Date:  2015-07-09       Impact factor: 3.402

7.  An integrated approach to epitope analysis II: A system for proteomic-scale prediction of immunological characteristics.

Authors:  Robert D Bremel; E Jane Homan
Journal:  Immunome Res       Date:  2010-11-02

8.  Naturally occurring IgG antibody levels to the Staphylococcus aureus protein IsdB in humans.

Authors:  Julie K Zorman; Mark Esser; Michael Raedler; Barry N Kreiswirth; Dlawer A A Ala'Aldeen; Nicholas Kartsonis; Steven S Smugar; Annaliesa S Anderson; Tessie McNeely; Jean Marie Arduino
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

Review 9.  Investigational drugs to treat methicillin-resistant Staphylococcus aureus.

Authors:  Cuong Vuong; Anthony J Yeh; Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Investig Drugs       Date:  2015-11-04       Impact factor: 6.206

Review 10.  Monoclonal Antibodies Targeting Surface-Exposed and Secreted Proteins from Staphylococci.

Authors:  Pietro Speziale; Giampiero Pietrocola
Journal:  Vaccines (Basel)       Date:  2021-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.